Salt: Influenza Vaccine
Therapeutic Description: Vaccines
In combination with methotrexate to improve physical function in patients with active rheumatoid arthritis unresponsive to DMARDs, including methotrexate. Treatment of ankylosing spondylitis in patients with severe axial symptoms, elevated serological markers of inflammation and who have responded inadequately to conventional therapy. Severe active Crohn's disease or fistulising Crohn's disease in patients unresponsive to corticosteroid and/or immunosuppressant therapy.
Adults: Rheumatoid Arthritis: 3 mg/kg by IV inf over 2 hours, repeated 2 weeks and 6 weeks after first inf, then every 8 weeks. Methotrexate must be given concur
Strength Pack Size PKR
1 Vialx.5 mL644.64

Your medicine formula resulted in the following types of medicine type. Please select to proceed.